Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system

Brain Research

Volumn 1367, Issue , 2011, Pages 22-32

  Yoshikawa, Keisuke ^a   Takei, Shiro ^a   Hasegawa Ishii, Sanae ^a   Chiba, Yoichi ^a   Furukawa, Ayako ^a   Kawamura, Noriko ^a   Hosokawa, Masanori ^a   Woodward, David F ^b   Watanabe, Kikuko ^c   Shimada, Atsuyoshi ^a  

^a INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF EAST ASIA   (Japan)

Author keywords

Enzyme; Immunohistochemistry; Myelin; Oligodendrocyte; Prostaglandin; Prostaglandin ethanolamide

Indexed keywords

CYCLOOXYGENASE 2; MYELIN BASIC PROTEIN; PROSTAGLANDIN D2 11 KETOREDUCTASE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; ENZYME LOCALIZATION; HISTOPATHOLOGY; IMMUNOREACTIVITY; MOUSE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE 2; DINOPROST; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYDROXYPROSTAGLANDIN DEHYDROGENASES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN SHEATH; OLIGODENDROGLIA; RATS; RATS, WISTAR;

MUS;

EID: 78650515190     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.019     Document Type: Article

References (42)

1. T. Bisogno, and V. Di Marzo Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9 2010 564 573
2. L.Y. Chen, K. Watanabe, and O. Hayaishi Purification and characterization of prostaglandin F synthase from bovine liver Arch. Biochem. Biophys. 296 1992 17 26
3. J. Chen, I. Matias, T. Dinh, T. Lu, S. Venezia, A. Nieves, D.F. Woodward, and V. Di Marzo Finding of endocannabinoids in human eye tissues: implications for glaucoma Biochem. Biophys. Res. Commun. 330 2005 1062 1067
4. Y. Chiba, A. Shimada, M. Satoh, Y. Saitoh, N. Kawamura, A. Hanai, H. Keino, Y. Ide, T. Shimizu, and M. Hosokawa Sensory system-predominant distribution of leukotriene A4 hydrolase and its colocalization with calretinin in the mouse nervous system Neuroscience 141 2006 917 927
5. H. Daiyasu, K. Watanabe, and H. Toh Recruitment of thioredoxin-like domains into prostaglandin synthases Biochem. Biophys. Res. Commun. 369 2008 281 286
6. A. Delassalle, B. Zalc, F. Lachapelle, M. Raoul, P. Collier, and C. Jacque Regional distribution of myelin basic protein in the central nervous system of quaking, jimpy, and normal mice during development and aging J. Neurosci. Res. 6 1981 303 313
7. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz, and D. Piomelli Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 1994 686 691
8. 2 alpha in asthmatic subjects Am. Rev. Respir. Dis. 130 1984 571 574
9. A.M. Hein, and M.K. O'Banion Neuroinflammation and memory: the role of prostaglandins Mol. Neurobiol. 40 2009 15 32
10. S. Inaga, T. Katsumoto, K. Tanaka, T. Kameie, H. Nakane, and T. Naguro Platinum blue as an alternative to uranyl acetate for staining in transmission electron microscopy Arch. Histol. Cytol. 70 2007 43 49
11. J. Kanfer, M. Parenty, C. Goujet-Zalc, M. Monge, L. Bernier, A.T. Campagnoni, A. Dautigny, and B. Zalc Developmental expression of myelin proteolipid, basic protein, and 2′, 3′-cyclic nucleotide 3′-phosphodiesterase transcripts in different rat brain regions J. Mol. Neurosci. 1 1989 39 46
12. H.J. Kim, J.I. Chung, S.H. Lee, Y.S. Jung, C.H. Moon, and E.J. Baik Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors Brain Res. 1193 2008 153 161
13. W. Kuchinke, O. Barski, K. Watanabe, and O. Hayaishi A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli Biochem. Biophys. Res. Commun. 183 1992 1238 1246
14. 2 agonist) on Cyr61 and connective tissue growth factor gene expression J. Biol. Chem. 278 2003 27267 27277
15. I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A.H. Krauss, L. Shi, C.E. Protzman, C. Li, Y. Liang, A.L. Nieves, K.M. Kedzie, R.M. Burk, V. Di Marzo, and D.F. Woodward Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J. Pharmacol. Exp. Ther. 309 2004 745 757
16. G.K. Matsushima, and P. Morell The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system Brain Pathol. 11 2001 107 116
17. B.A. Miller, J.M. Crum, C.A. Tovar, A.R. Ferguson, J.C. Bresnahan, and M.S. Beattie Developmental stage of oligodendrocytes determines their response to activated microglia in vitro J. Neuroinflamm. 4 2007 28
18. H. Moriuchi, N. Koda, E. Okuda-Ashitaka, H. Daiyasu, K. Ogasawara, H. Toh, S. Ito, D.F. Woodward, and K. Watanabe Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily J. Biol. Chem. 283 2008 792 801
19. S. Narumiya Prostanoids and inflammation: a new concept arising from receptor knockout mice J. Mol. Med. 87 2009 1015 1022
20. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
21. K.A. Nave, and B.D. Trapp Axon-glial signaling and the glial support of axon function Annu. Rev. Neurosci. 31 2008 535 561
22. S. Saleem, A.S. Ahmad, T. Maruyama, S. Narumiya, and S. Dore PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia Neurotox. Res. 15 2009 62 70
23. D.L. Sherman, and P.J. Brophy Mechanisms of axon ensheathment and myelin growth Nat. Rev. Neurosci. 6 2005 683 690
24. A. Shimada, M. Satoh, Y. Chiba, Y. Saitoh, N. Kawamura, H. Keino, M. Hosokawa, and T. Shimizu Highly selective localization of leukotriene C4 synthase in hypothalamic and extrahypothalamic vasopressin systems of mouse brain Neuroscience 131 2005 683 689
25. W.L. Smith, L.J. Marnett, and D.L. DeWitt Prostaglandin and thromboxane biosynthesis Pharmacol. Ther. 49 1991 153 179
26. T.J. Sprinkle, M.E. Zaruba, and G.M. McKhann Activity of 2′, 3′-cyclic-nucleotide 3′-phosphodiesterase in regions of rat brain during development: quantitative relationship to myelin basic protein J. Neurochem. 30 1978 309 314
27. T. Suzuki, Y. Fujii, M. Miyano, L.Y. Chen, T. Takahashi, and K. Watanabe cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase J. Biol. Chem. 274 1999 241 248
28. T. Suzuki-Yamamoto, M. Nishizawa, M. Fukui, E. Okuda-Ashitaka, T. Nakajima, S. Ito, and K. Watanabe cDNA cloning, expression and characterization of human prostaglandin F synthase FEBS Lett. 462 1999 335 340
29. T. Suzuki-Yamamoto, K. Toida, K. Watanabe, and K. Ishimura Immunocytochemical localization of prostaglandin F synthase II in the rat spinal cord Brain Res. 969 2003 27 35
30. 2alpha receptor FP and prostaglandin F synthase-I in the spinal cord J. Lipid Res. 50 2009 1996 2003
31. H. Tamaki, and S. Yamashina Improved method for post-embedding cytochemistry using reduced osmium and LR white resin J. Histochem. Cytochem. 42 1994 1285 1293
32. A.N. Verity, and A.T. Campagnoni Regional expression of myelin protein genes in the developing mouse brain: in situ hybridization studies J. Neurosci. Res. 21 1988 238 248
33. J.J. Volpe Neurology of the Newborn 5th ed. 2008 Saunders Elsevier Philadelphia
34. Z. Wan, D.F. Woodward, and W.D. Stamer Endogenous bioactive lipids and the regulation of conventional outflow facility Expert Rev. Ophthalmol. 3 2008 457 470
35. K. Watanabe Prostaglandin F synthase Prostaglandins Other Lipid Mediat. 68-69 2002 401 407
36. 2. Purification and properties of prostaglandin F synthetase from bovine lung J. Biol. Chem. 260 1985 7035 7041
37. K. Watanabe, Y. Iguchi, S. Iguchi, Y. Arai, O. Hayaishi, and L.J. Roberts 2nd Stereospecific conversion of prostaglandin D2 to (5Z, 13E)-(15S)-9 alpha-11 beta, 15-trihydroxyprosta-5, 13-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proc. Natl Acad. Sci. USA 83 1986 1583 1587
38. K. Watanabe, Y. Fujii, K. Nakayama, H. Ohkubo, S. Kuramitsu, H. Kagamiyama, S. Nakanishi, and O. Hayaishi Structural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frog Proc. Natl Acad. Sci. USA 85 1988 11 15
39. D.F. Woodward, R.W. Carling, C.L. Cornell, H.G. Fliri, J.L. Martos, S.N. Pettit, Y. Liang, and J.W. Wang The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products Pharmacol. Ther. 120 2008 71 80
40. D.F. Woodward, Y. Liang, and A.H. Krauss Prostamides (prostaglandin- ethanolamides) and their pharmacology Br. J. Pharmacol. 153 2008 410 419
41. P.I. Yakovlev, and A.R. Lecours The myelogenetic cycles of regional maturation of the brain Minkowski Regional Developments of the Brain in Early Life 1967 Blackwell Scientific Oxford 3 71
42. K. Yoshikawa, Y. Kita, K. Kishimoto, and T. Shimizu Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2 J. Biol. Chem. 281 2006 14663 14669